ILC2s are enriched in nasal polyps from chronic rhinosinusitis patients and skin biopsies from atopic dermatitis patients and are among the main producers of IL-5 and IL-13 in the lungs of asthmatic patients [158]. This evidence concerns the gene IL5 and nasal cavity polyp.